ClinicalTrials.gg
CompletedNCT07827846Updated Sep 18, 2026

Investigation of the Effects of Exercise in Individuals With Juvenile Hallux Valgus

An interventional study of Toe Spread Out Exercises in Juvenile Hallux Valgus, Ultrasound and Shear Wave Elastography, sponsored by Ankara Yildirim Beyazıt University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 9 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-18.

Sponsored by Ankara Yildirim Beyazıt University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Nov 2025, registered Sep 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Not applicable
Ages
9 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 11 studies in Hallux Valgus with a site in Turkey — 4 open to participants now, 4 under way, none of them phase 3. Hallux Valgus · Turkey.

Started
2025
with 3 others
No phase
7 of 11
3 open now
Registered
11th of 11
by date
Lead sponsor
1 of 11
Ankara Yildirim Beyazıt University

Among the 11 studies in Hallux Valgus with a site in Turkey, this one is one of 4 that started in 2025, is one of 7 with no phase, and was the 11th registered.

Hallux Valgus

157 studies on the registry are indexed under Hallux Valgus; 36 are open to participants now.

This study's enrollment of 4 is below the median of 58 across 119 interventional studies indexed under Hallux Valgus.

Browse Hallux Valgus studies →

Open to participants now

4 of the 11 studies in Hallux Valgus with a site in Turkey are open now, in 1 country. Each count lists the studies.

All 4 open studies →

Where they have run

Who these studies take

Of the 21 Hallux Valgus studies recruiting now, 10 (48%) set no upper age limit and 7 (33%) stop at 75 or younger; 3 take children under 18; 4 take healthy volunteers.

This study: 9 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Hallux Valgus with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to evaluate the short- and long-term effects of toe spread-out exercises, performed under supervision for 3 months, on the angular severity of deformity and the electromechanical activity, stiffness, and thickness of the abductor hallucis muscle, as well as its contribution to functional status, in individuals with juvenile hallux valgus.

03

Conditions studied

  • Juvenile Hallux Valgus
  • Ultrasound
  • Shear Wave Elastography

Browse trials for

04

Who can participate

Ages eligible
9 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of JHV,
  • Mild or moderate deformity confirmed radiographically,
  • Flexible hallux valgus deformity,
  • Willingness to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Neurological disorders,
  • Systemic diseases,
  • Spinal disorders (e.g., lumbar disc herniation, lumbar spinal stenosis, or scoliosis),
  • Intermittent claudication,
  • Idiopathic numbness or tingling of the lower extremities,
  • Previous lower-extremity surgery,
  • Fractures, ligament injuries, or muscle injuries involving the lower extremities within the previous six months,
  • Treatment for any foot-related condition during the previous six months.

Withdrawal Criteria:

  • Unable to correctly perform the exercise protocol,
  • Failed to attend scheduled assessments,
  • Unable to continue the prescribed intervention,
  • SWE measurements could not be obtained.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
4 participants (actual)

Study arms

  • Experimental
    Intervention Group

    Other: Toe Spread Out Exercises

Interventions

  • OtherToe Spread Out Exercises

    Standart protocol toe spread out exercise

06

What researchers measure

Primary outcomes

  1. Cross sectional area

    CSA of m. abductor hallucis with ultrasound (cm²)

    Time frame: From enrollment to the end of treatment at 12 weeks

  2. Shear Wave Elastography

    Measurement SWE with ultrasound (m. abductor hallucis) (cm)

    Time frame: From enrollment to the end of treatment at 12 weeks

  3. Multidimensional Nil Hallux Valgus Scale

    The scale has a score range of 0-60, with higher score indicating increased HV symptoms, complaints, and functional disorder.

    Time frame: From enrollment to the end of treatment at 12 weeks

  4. Hallux Valgus Angle (x-ray)

    Time frame: From enrollment to the end of treatment at 12 weeks

07

Study locations

1 site
  • Ankara Yildirim Beyazıt University
    Ankara, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2025 to primary completion in Nov 2025, 0 months.

Of 51 non-industry interventional studies with no phase under Hallux Valgus, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 55. This study's 0 months is below that.

Counting every sponsor, half of 56 studies reached it within 26 months; a quarter within 11 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 9, 2026
First posted
Sep 18, 2026
StartActual
Nov 15, 2025
Primary completionActual
Nov 20, 2025
CompletionActual
Feb 28, 2026
Last update
Sep 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07827846
Responsible party
Bahar Anaforoglu (Professor, Ankara Yildirim Beyazıt University) — Principal investigator
First posted
Sep 18, 2026
Start date
Nov 15, 2025
Primary completion
Nov 20, 2025
Completion
Feb 28, 2026
Last update
Sep 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion